Full-Time

Applied AI Data Scientist

Updated on 9/9/2026

RELX

RELX

1,001-5,000 employees

Global information analytics and decision tools

No salary listed

Company Historically Provides H1B Sponsorship

New York, NY, USA

In Person

Full-time, on-site presence in New York City is required. Occasional travel to customer sites may be required.

Category
AI & Machine Learning (1)
Required Skills
LLM
Scikit-learn
Microsoft Azure
Python
Data Science
SQL
Machine Learning
A/B Testing
RAG
AWS
Pandas
LangGraph
Observability
LangChain
NumPy
Google Cloud Platform

Get referred to RELX

See people who can refer or advise you

Requirements
  • At least 6 years of experience as a Data Scientist, Applied Scientist, Machine Learning Engineer, or related quantitative professional, with a track record of shipping data-driven solutions.
  • A strong foundation in statistics and experimental design, including hypothesis testing, A/B testing, causal inference, and confidence and uncertainty quantification.
  • Strong programming skills in Python and its data stack, including pandas, NumPy, and scikit-learn, plus SQL for querying and shaping large datasets.
  • Hands-on experience developing and evaluating large language model-powered or machine learning solutions, ideally in production-oriented settings.
  • Demonstrated ability to design rigorous evaluation methodologies and metrics for artificial intelligence and machine learning systems, including offline and online evaluation, error analysis, benchmark construction, and quality measurement.
  • Practical experience with prompting, retrieval-augmented generation, embeddings, semantic search, and structured generation.
  • Experience with the full modeling lifecycle, including data exploration, feature engineering, model training and validation, and monitoring for drift and degradation in production.
  • Familiarity with modern AI engineering frameworks and tooling such as LangChain, LangGraph, LlamaIndex, OpenAI APIs, Anthropic APIs, or equivalent systems.
  • Experience working with AI and machine learning systems and data infrastructure on AWS, Azure, or Google Cloud Platform.
  • Ability to translate ambiguous business problems into well-scoped, measurable questions and communicate findings clearly to engineering, product, and business stakeholders.
  • Ability to work in evolving environments and collaborate across teams to deliver data- and AI-powered features and workflows.
Responsibilities
  • Spend time with lawyers, legal operations teams, and internal subject-matter experts to understand customer workflows and operational challenges through direct engagement.
  • Translate ambiguous customer pain points into well-scoped, measurable problem statements.
  • Collaborate with customers and internal stakeholders to prototype, validate, and refine AI-powered workflows and user experiences based on feedback and observed needs.
  • Bring the customer voice into model choices, evaluation criteria, and product trade-offs.
  • Design and run experiments that turn applied research and emerging techniques into validated capabilities for legal use cases.
  • Develop and iterate on large language model-powered approaches such as prompt engineering, retrieval strategies, context management, structured generation, and lightweight agent patterns.
  • Design and prototype agentic AI systems, including long-running autonomous agents that plan, call tools, and reason over multiple steps.
  • Build orchestration, state and context management, tool integration, and feedback loops that enable long-running agents to run reliably, recover from errors, and improve over time.
  • Build rapid, runnable prototypes to test ideas, de-risk assumptions, and explore user-experience and architectural trade-offs.
  • Analyze model and pipeline behavior, including error analysis, failure modes, and data quality issues, and turn findings into prioritized improvements.
  • Contribute production-oriented code and partner with engineers to harden promising prototypes for production.
  • Use LangChain, LangGraph, LlamaIndex, OpenAI SDKs, Google ADK, and Anthropic or Claude APIs to prototype and refine AI capabilities.
  • Design domain-aware evaluation methodologies for legal AI covering accuracy, comprehensiveness, citation grounding, hallucination detection, and other quality dimensions.
  • Define offline and human-in-the-loop evaluation approaches, metrics, and reusable benchmarks.
  • Build and run evaluation harnesses to compare models, prompts, retrieval strategies, and configurations, and track quality and regressions over time.
  • Evaluate long-running, multi-step agents by measuring trajectory quality, tool-use correctness, and agent feedback-loop behavior.
  • Partner with engineers to integrate evaluation, monitoring, and observability into production AI applications.
  • Balance innovation with latency, cost, reliability, and explainability constraints when recommending approaches.
  • Partner with applied AI engineers, machine learning engineers, designers, product managers, legal subject-matter experts, and platform engineering teams.
  • Explain model behavior, limitations, and safeguards to technical and non-technical stakeholders in high-stakes environments.
  • Contribute reusable evaluation methods, datasets, and findings to shared AI platform capabilities and team practices.
Desired Qualifications
  • Experience in legal technology, enterprise software as a service, compliance, financial services, healthcare, or other regulated industries.
  • Experience with agentic workflows, multi-step reasoning, or tool-calling systems, including long-running agent design, autonomous-agent orchestration, and supporting harness and feedback-loop engineering.
  • Familiarity with retrieval and ranking optimization, hybrid search, or knowledge graph integration.
  • Experience with human-in-the-loop evaluation, annotation workflows, or building internal benchmarks.
  • Experience with AI guardrails, hallucination detection, responsible AI, or grounded and citation-based generation.
  • Familiarity with fine-tuning or model adaptation techniques.
  • Experience contributing to AI copilots, AI assistants, or workflow automation systems.
  • Open-source contributions, technical blogging, conference speaking, or AI and machine learning community involvement.

RELX is a global provider of information-based analytics and decision tools for professionals across scientific, technical, medical, legal, risk, business, and exhibitions industries. It operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products combine large datasets, analytics, and decision-support tools to help researchers, healthcare professionals, lawyers, and business leaders make informed choices, improve productivity, and achieve better outcomes. Revenue mainly comes from subscriptions, with additional income from transactional sales and advertising. RELX differentiates itself through its deep data assets, specialized industry knowledge, and multi-segment offerings that span content, analytics, and decision-support services. The company pursues a goal of delivering trusted information and insights while supporting corporate responsibility and alignment with the UN SDGs through its products and partnerships.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1894

Get referred to RELX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue grew 7%; Legal grew 10%; Risk grew 8%.
  • February 24, 2026 Lexis+ with Protégé launched globally, expanding AI workflow adoption.
  • September 3, 2026 Doctrine closes, targeting one million European legal professionals.

What critics are saying

  • Anthropic and Thomson Reuters compressed legal AI pricing after February 2026 market shock.
  • Harvey and Legora court law schools in 2026, training future buyer cohorts elsewhere.
  • Exhibitions face Middle East event uncertainty through 2026, threatening margins and calendar-dependent cash flows.

What makes RELX unique

  • LexisNexis’ 200 billion-document corpus still beats generic legal AI models.
  • September 3, 2026 Doctrine acquisition deepens RELX’s European legal AI workflow moat.
  • H1 2026 subscriptions supplied 62% of revenue, stabilizing cash generation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Family Planning Benefits

Health Savings Account/Flexible Spending Account

Flexible Work Hours

Remote Work Options

Company News

Citybiz
Apr 28th, 2026
RELX to Acquire Legaltech Platform Doctrine in European AI Push

RELX Group has entered into an agreement to acquire French legal technology company Doctrine, a move that would expand its... Read More

Business Insider
Mar 1st, 2026
LexisNexis CEO dismisses AI threat as company reports 7% revenue growth

LexisNexis CEO Sean Fitzpatrick has dismissed investor concerns that AI threatens the legal software giant, saying proprietary data gives it a competitive advantage. Shares of parent company Relx fell 14% on 3 February following Anthropic's launch of an AI agent that drafts legal briefs, and are down 17% year-to-date. Fitzpatrick said LexisNexis's database of 200 billion legal documents, including content from Shepard's Citations dating to 1873, cannot be replicated by AI model makers. The company doesn't license its proprietary data to general-purpose AI providers. Relx reported 7% revenue growth for 2025 and 9% increase in adjusted operating profit, driven by customers adopting AI tools. LexisNexis is hiring and hasn't conducted AI-related redundancies.

Yahoo Finance
Feb 22nd, 2026
RELX's LexisNexis launches AI-powered identity management platform for healthcare

LexisNexis Risk Solutions, a wholly owned subsidiary of RELX, has launched a new identity management platform for the healthcare sector. Announced on 19 February, the tool combines identity verification, matching and enrichment capabilities with AI-powered authentication to enhance security throughout patients' healthcare journeys. The platform integrates LexisNexis IDVerse and offers enhanced identity verification, resolution and fraud protection. For healthcare professionals, it accelerates onboarding processes, automates processing and provides digital checks to prevent fraud. RELX is a global information and analytics company serving professional and business customers across scientific, technical, medical, legal and risk management markets.

PR Newswire
Jun 4th, 2025
Elsevier Unveils Rigorous Evaluation Framework To Mitigate Risk In Generative Ai Clinical Decision Support Tools

Clinician-centered framework will be featured in upcoming issue of the Open AccessJournal of the American Medical Informatics Association (JAMIA)Initial evaluations of ClinicalKey AI show high accuracy and usefulness in responses amongst cliniciansNEW YORK, June 4, 2025 /PRNewswire/ -- Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for assessing the performance and safety of generative AI-powered clinical reference tools. This innovative approach has been developed for all Elsevier Health generative AI solutions, including ClinicalKey AI, Elsevier's advanced clinical decision support platform, and sets a new standard for responsible AI integration in healthcare. It will be featured in a future issue of the Open Access Journal of the American Medical Informatics Association (JAMIA).The framework, designed with input from clinical subject matter experts across multiple specialties, evaluates AI-generated responses along five critical dimensions: query comprehension, response helpfulness, correctness, completeness, and potential for clinical harm. It serves as a comprehensive assessment to ensure that AI-powered tools not only provide accurate and relevant information but also align with the practical and current needs of healthcare professionals at the point of care.Omry Bigger, President of Clinical Solutions at Elsevier: "This evaluation framework not only supports innovation and advancements to improve patient care but adds an extra layer of review and assessment to ensure physicians are armed with the most accurate information possible. It's a critical step in the implementation of responsible AI for healthcare providers and patients."In a recent evaluation study of ClinicalKey AI, Elsevier worked with a panel of 41-board certified physicians and clinical pharmacists to rigorously test responses generated by the tool for a diverse set of clinical queries. That panel evaluated 426 query-response pairs, and results demonstrated impressive performance, with 94.4% of responses rated as helpful, 95.5% assessed as completely correct, with just 0.47% flagged for potential improvements.Leah Livingston, Director of Generative AI Evaluation for Health Markets at Elsevier, said: "These results reflect not just strong performance, but the real value of bringing clinicians into the evaluation process

PharmiWeb
May 7th, 2025
Elsevier Adds Half A Million Records From Clinicaltrials.Gov To Embase, Enabling A Seamless Search Experience In The World’S Most Comprehensive Biomedical Database

London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Researchers will be able to conduct more comprehensive evidence and literature searches while having the confidence they will never miss important updates relevant to their drug, therapy, or medical device. Clinical trials data is a vital component of biomedical literature search, helping pharmaceutical and medical device companies stay informed about the latest scientific advancements, regulatory requirements, and competitive insights to support evidence-based decision-making. However, gathering data from multiple sources is currently prone to errors and is time-consuming, such as the duplication of search results, which slows research and regulatory processes. As new therapies and devices are developed and RD organizations seek collaborative partners, they must undertake thorough searches and justifications of evidence